Listen

Listen: A controversial desire drug, courtroom genealogy, & the quest for longer life

Is desire a matter of medicine? Can you convict on genealogy? And what do you get the alleged bride who has it all? We discuss all that and more on...

Read more
Listen to DanStem podcast hosting James Briscoe

James Briscoe is a Group leader at the Francis Crick Institute in London, where he and his lab work on the development of the spinal chord using both molecular biology...

Read more
Listen: Biohacking meets bureaucracy, and the latest twist in CRISPR world

Is biohacking a crime? Who came up with the latest CRISPR trick? And did Rage Against the Machine sell out? We discuss all that and more on the latest episode...

Read more
Listen: The future of cancer treatment, blockbusters interrupted, & an infamous biotech party

Who won ASCO? Is pharma sandbagging its blockbusters? And what do gladiators have to do with biotech? We discuss all that and more on the latest episode of “The Readout...

Read more
Listen: Feuding professors, failing businesses, and journalism 101

Who’s guilty of “clickbait”? Are spit tubes a bad business? And why are academics emulating Pusha T? We discuss all that and more on the latest episode of “The Readout...

Read more
Listen: Your ASCO preview, genetic whiplash, and a journalist’s experience with cancer

What should you watch for at the year’s biggest cancer conference? Why are people having 23andMe-induced identity crises? And what’s it like to be at once a journalist and a...

Read more
Listen: Drug pricing partisanship, tech’s march into health care, and Tinder for clinical trials

[ad_1] Has drug price reform already stalled? How far has tech come in medicine? And should there be an app for that? We discuss all that and more on the...

Read more
Healthcare leaders listen up: Personalized wellbeing is the next frontier

[ad_1] Personalized medicine shouldn’t be practiced in just clinical settings but for all aspects of a person’s health and wellbeing to truly transform the industry and control burgeoning spend. Source...

Read more
Listen: Pharma felonies, cardiac CRISPR, and a strange day at the FDA

[ad_1] Are law-breaking pharma executives the new mob bosses? Can genome editing prevent heart attacks? And can the FDA regulate drug prices? We discuss all that and more on the...

Read more
Listen: When scientists get mad online, for-profit cancer care, & the perils of naming a startup

[ad_1] Who gets to be “influential”? Should you be skeptical of for-profit hospitals? And should George Lucas fire his attorneys? We discuss all that and more on the latest episode...

Read more
STAT Plus: How does Biogen move beyond its Alzheimer’s drug blowup? Listen for the clues

[ad_1] When Biogen (BIIB) reports first-quarter earnings on Wednesday morning, investors will be listening for what, if anything, management says about the biotech’s path forward in the wake of its...

Read more
Listen: Democratizing CRISPR, drugging the undruggable, and reading pharma’s fine print

[ad_1] Who gets to “play God”? Can old technologies learn new tricks? And what does “drug price” even mean? We discuss all that and more on the latest episode of...

Read more
Listen: Trump’s drug pricing foot soldier, Gilead’s uncertain future, & transpacific angst

[ad_1] How do you sell lefty ideas to righty politicians? What’s going on at Gilead Sciences? And why are biotech investors freaking out? We discuss all that and more on...

Read more
Listen: Cheaper insulin, the next Juul, and diagnosing disease with sound

[ad_1] What if pharma just charged less for drugs? Can speaking three syllables reveal whether you’re depressed? And why is Snoop Dogg selling erectile dysfunction pills on TV? We discuss...

Read more
Listen: How startups stop, the new FDA boss, and Theranos on the big screen

[ad_1] Who deserves credit for a new gene therapy? How do you push stop on a startup? And what does MC Hammer have to do with Theranos? We discuss all...

Read more
Listen: Every conceivable angle of Scott Gottlieb’s FDA resignation

[ad_1] Why is Scott Gottlieb quitting the FDA? Who will replace him? And what’s the proper elastane content of a skinny jean? We discuss all that and more on the...

Read more
P002 WHEN THE PATIENT VOICE IS HEARD IN EDUCATION, DOES THE CLINICIAN LISTEN? DUAL TRACK PATIENT/PROVIDER EDUCATION IN IBD INCORPORATING PATIENTS AS LEARNERS AND FACULTY

[ad_1] It is postulated that patient inclusion in planning/execution of continuing medical education (CME) activities may better engage providers, reinforce learning, and improve outcomes. RMEI Medical Education’s (RMEI’s) proprietary Clinical...

Read more
Want to integrate care? Listen to the patient

[ad_1] Integrated care and interoperability is complex if it has to be managed by experts. It becomes pretty easy once you let the patient have a say, according to Philipp...

Read more
Listen: CEOs at the Senate, merger mania, and sleuthing startups

[ad_1] Is this the age of the big biotech buyout? Is cold brew a business expense? And how do you pronounce “Gonzalez”? We discuss all that and more on the...

Read more
LISTEN: A big scoop on opioid marketing

[ad_1] What did an opioid patriarch say under oath? Why did everyone want to know so badly? And how might it shape the conversation around the opioid crisis? We discuss...

Read more